913 Views | 0 Downloads
Address correspondence and reprint requests to Dr. David W. Loring, Department of Neurology, Emory University, 101 Woodruff Circle, Suite 6000, Atlanta, GA 30322dloring@emory.edu
Study funding: Funding for the original TPM obesity trial (Study ID NCT00236613) was provided by Johnson & Johnson Pharmaceutical Research & Development, LLC. Post hoc analyses were conducted under the direction of JJPRD statisticians (Steve Ascher and C.V. Damaraju).
Dr. Loring serves/has served on scientific advisory boards for the Epilepsy Foundation and Sanofi-Aventis; serves as a consulting editor for the Journal of Clinical and Experimental Neuropsychology, as contributing editor for Epilepsy Currents, and on the editorial board of Neuropsychology Review; serves as a consultant for NeuroPace, Inc., Sanofi-Aventis, and UCB; receives royalties from the publication of Neuropsychological Assessment, 4th ed. (Oxford University Press, 2004) and INS Dictionary of Neuropsychology (Oxford University Press, 1999); estimates that 50% of his clinical effort involves neuropsychological testing; and receives research support from NeuroPace, Inc., SAM Technology Inc., Myriad Pharmaceuticals, Inc., Novartis, the NIH/NINDS, and the Epilepsy Foundation. Dr. Williamson is a salaried employee of Ortho-McNeil Janssen Scientific Affairs, LLC; and receives stock and stock options from Johnson & Johnson, parent company of Ortho-McNeil Janssen Scientific Affairs, LLC. Dr. Meador serves on the editorial boards of Neurology and Behavior & Neurology, Epilepsy and Behavior, Epilepsy Currents, Epilepsy.com, and the Journal of Clinical Neurophysiology and on the Professional Advisory Board for the Epilepsy Foundation; received travel support from Sanofi-Aventis; and received research support from GlaxoSmithKline, Eisai Inc., Marinus Pharmaceuticals, Inc., Myriad Genetics, Inc., NeuroPace, Inc., Pfizer, SAM Technology Inc., Schwartz Pharma (UCB), the NIH/NINDS, and the Epilepsy Foundation. Dr. Wiegand is a salaried employee of Johnson & Johnson Pharmaceutical Services LLC. Dr. Hulihan is a salaried employee of Ortho-McNeil Janssen Scientific Affairs, LLC; and receives stock and stock options from Johnson & Johnson, parent company of Ortho-McNeil Janssen Scientific Affairs, LLC.
Copyright © 2011 by AAN Enterprises, Inc.